North Ryde. Cochlear's hedging program

Bionic ear manufacturer, Cochlear, which expects to move into its new $130 million global HQ at Macquarie University by year-end, remains confident its elaborate hedging program will help protect it against the soaring Australian dollar as it rolls out its Nucleus 5 implant system offshore. The company generates about 95 per cent of its sales in foreign currency, The Australian Financial Review said.

North Ryde. Record result for Cochlear

Bionic ear manufacturer, Cochlear, which expects to move into its new $130 million global HQ at Macquarie University by year-end, posted a 19 per cent increase in full-year profit to $155.2 million.

Industry-based reasearch university

Macquarie University is one step closer to its vision of becoming Australia's leading industry-based research university with the signing of a heads of agreement with global leader in implantable hearing solutions, Cochlear Limited, to move its headquarters from Lane Cove to a 26,000-square-metre international corporate and high-tech manufacturing facility on the campus by 2010.

Part of this vision is the development of Australia's first private teaching hospital on a university campus. This $150 million initiative will e the centrepiece of Macquarie's developments in medicine via the Australian School of Advanced Medicine. The university's goal is to develop about $1 billion of new research and teaching facilities jointly with industry over the next five years.